Platform Validation & Partnership

About QurieGen

QurieGen is an early-stage biotechnology company pioneering a 'lab-in-the-loop' platform that integrates proprietary single-cell multi-omics data generation with AI-driven simulation. Its core technology, QuRIE-seq, simultaneously captures time-resolved transcriptomic and proteomic data from individual cells to quantify dynamic responses to perturbations. The company's primary business model is partnering with pharmaceutical and biotech firms, offering its platform and predictive models to de-risk and accelerate drug discovery in oncology and immunology. As a private, likely pre-revenue entity, QurieGen is positioning itself as a key enabler in the shift towards more predictive, biology-driven R&D.

Therapeutic Areas